Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Neoplasia (New York, N.Y.)|September 5, 2017
FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer CellsLukasz Turczyk, Kamila Kitowska, Magdalena Mieszkowska, et al.
Journal of Cell Science|September 28, 2018
CD151 regulates expression of FGFR2 in breast cancer cells via PKC-dependent pathwaysRafal Sadej, Xiaohong Lu, Lukasz Turczyk, et al.
Archives of Medical Science : AMS|February 29, 2012
TRAIL protein expression in breast cancer cells correlates with nuclear gradeAdam Bilski, Grażyna Pasz-Walczak, Robert Kubiak, et al.
DNA and Cell Biology|February 11, 2014
TP53 promoter methylation in primary glioblastoma: relationship with TP53 mRNA and protein expression and mutation statusDorota Jesionek-Kupnicka, Malgorzata Szybka, Beata Malachowska, et al.
Breast Cancer Research and Treatment|January 10, 2014
A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancerWolfgang Janni, Tomasz Sarosiek, Boguslawa Karaszewska, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|May 19, 2015
Prognostic value of HER3, PTEN and p-HER2 expression in patients with HER2positive breast cancerSylwia Dębska-Szmich, Renata Kusińska, Urszula Czernek, et al.
Breast (Edinburgh, Scotland)|September 20, 2015
Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancerWolfgang Janni, Tomasz Sarosiek, Boguslawa Karaszewska, et al.
Molecular Biology Reports|February 10, 2012
Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancerAgnieszka Kolacinska, Wojciech Fendler, Janusz Szemraj, et al.
Molecular Cancer Research : MCR|June 18, 2009
CD151 regulates tumorigenesis by modulating the communication between tumor cells and endotheliumRafal Sadej, Hanna Romanska, Gouri Baldwin, et al.
Cancer Genetics and Cytogenetics|December 23, 2008
High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutationsEmilia Jesien-Lewandowicz, Dorota Jesionek-Kupnicka, Izabela Zawlik, et al.
Pageof 8